You just read:

Nordic Nanovector: Promising Results From Preclinical Studies With a Novel CD37-targeted Alpha Therapy for B-cell Tumours Presented at TAT11

News provided by

Nordic Nanovector

Apr 02, 2019, 01:10 ET